Gainers
- BiondVax Pharmaceuticals BVXV shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding shares is at $39.3 million.
- Aptorum Group APM shares rose 13.86% to $1.56. The company's market cap stands at $55.5 million.
- HOOKIPA Pharma HOOK stock increased by 13.29% to $1.79. The market value of their outstanding shares is at $97.8 million. The company's, Q4 earnings came out today.
- NeuBase Therapeutics NBSE shares increased by 12.69% to $2.22. The company's market cap stands at $72.7 million.
- Lucid Diagnostics LUCD stock increased by 11.88% to $3.39. The market value of their outstanding shares is at $124.7 million.
- MorphoSys MOR stock rose 9.46% to $7.17. The company's market cap stands at $979.3 million.
Losers
- Hyperfine HYPR shares declined by 8.8% to $3.22 during Thursday's pre-market session. The company's market cap stands at $225.5 million. The company's, Q4 earnings came out yesterday.
- Impel NeuroPharma IMPL shares decreased by 8.11% to $7.37. The company's market cap stands at $169.8 million. As per the press release, Q4 earnings came out today.
- Immutep IMMP shares declined by 7.9% to $3.15. The market value of their outstanding shares is at $269.0 million.
- GBS GBS stock decreased by 7.59% to $0.89. The market value of their outstanding shares is at $13.2 million.
- Neogen NEOG shares decreased by 7.53% to $31.2. The company's market cap stands at $3.3 billion. As per the news, the Q3 earnings report came out today.
- Diffusion Pharmaceuticals DFFN shares declined by 7.38% to $0.31. The market value of their outstanding shares is at $32.0 million. As per the press release, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in